Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) SHH

55.10

-0.39(-0.70%)

Updated at August 19 11:29AM

Currency In CNY

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Address

No. 399, Libing Road

Shanghai, 201203

China

Phone

86 21 8029 7676

Sector

Healthcare

Industry

Biotechnology

Employees

995

First IPO Date

July 22, 2020

Key Executives

NameTitlePayYear Born
Lirong ZhengAccounting Supervisor0N/A
Ms. Yongzhi SunDirector & Financial Manager01975
Mr. Qi ZhangSecretary of Board of Directors01984
Ms. Yanli LiuGM & Director01981

Description

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.